Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC

Ruth C. Travis(University of Oxford), Timothy J. Key(University of Oxford), Krasimira Aleksandrova(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Snorri Björn Rafnsson(University of Edinburgh), Jenny Chang‐Claude(Universität Hamburg), Esther Molina‐Montes(Universidad de Granada), Rudolf Kaaks(German Cancer Research Center), Mattias Johansson(Centre international de recherche sur le cancer), Veronika Fedirko(The University of Texas MD Anderson Cancer Center), Kay‐Tee Khaw(University of Cambridge), ­Rosario ­Tumino(Azienda Usl 8 Arezzo), Afshan Siddiq, Tina Karapetyan(Hellenic Health Foundation), Heiner Boeing(German Institute of Human Nutrition), Antonia Trichopoulou(Academy of Athens), Eva Ardanáz, Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Elio Ríboli(Imperial College London), Naomi E. Allen(University of Oxford), Alison Price(Malawi Epidemiology and Intervention Research Unit), Nerea Larrañaga(Basque Government), Anne Tjønneland(University of Copenhagen), José María Huerta(Instituto Murciano de Investigación Biosanitaria), Paolo Vineis(Imperial College London), Nina Føns Johnsen(Danish Cancer Society), Vittorio Krogh(Istituti di Ricovero e Cura a Carattere Scientifico), María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), Carlos A. González(Bellvitge University Hospital), Teresa Norat(Imperial College London), H. Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Paul N. Appleby, Kim Overvad(Aarhus University), J. Ramón Quirós(Gobierno del Principado de Asturias), Pär Stattin(Uppsala University Hospital)
Cancer Causes & Control
May 21, 2012
Cited by 29


Related Papers